Follow us on Twitter
Below you will find current and archived press releases for your associated company. Navigate by selecting the year in the list below and click on the press release you want to read. Distribution takes place with a maximum of five minutes delay from press release.
OssDsign AB (publ) announces that the Annual Report for 2023 is now available as a PDF on the company's website, www.ossdsign.com. A PDF version i...
Uppsala, May 30, 2024. Today, OssDsign AB (publ.) announces that the company continues its successful penetration of the U.S. orthobiologics marke...
The shareholders in OssDsign AB, reg. no. 556841-7546, are hereby given notice to attend the annual general meeting at 10:00 am on Tuesday 25 June...
Adjusting to other dates in the company's financial calendar, OssDsign has decided to change the annual report release date to June 4, 2024. Previ...
We have successfully entered a new era as a pure play orthobiologics company
OssDsign AB (publ) announces that the interim report for Q1 2024...
Uppsala, Sweden, April 29 - OssDsign AB (publ.) today announces that the company has been awarded a new Veteran Affairs (VA) contract which covers...
Uppsala, Sweden, April 2 - OssDsign AB (publ.) today announces that the company has been awarded a new group purchasing (GPO) agreement for Bone a...
OssDsign AB (publ.) today announces that the company's current VP of Strategy, Business Development and Regulatory Affairs, Tom Buckland, has been...
OssDsign AB (publ) announces that the interim report for Q4 2023 is now available as a PDF on the company's website www.ossdsign.com/reports. A PD...
Uppsala, January 24, 2024. OssDsign AB (publ.) today announces that the previously communicated outstanding 12-month results from the clinical stu...
Uppsala, January 9, 2024. OssDsign AB (publ.) today announces that positive data from the clinical study TOP FUSION has been submitted to a peer-r...
